Abstract
A Phase I Study of PD 0332991: Complete CDK4/6 Inhibition and Tumor Response In Sequential Combination with Bortezomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have